Concepedia

Quanren Wang

QW

5

Publications

282

Citations

5

H-Index

2013

Active since

Affiliations

Chinese Academy of Sciences(Current)

Shanghai Institute of Materia Medica

University of Chinese Academy of Sciences

Quanren Wang is an author at Chinese Academy of Sciences specializing in tumor biology, cell biology, and breast cancer.

Top concepts

Publications per year

2013–2020

5

Publications

5

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models

Fei Long, Ye He, Haoyu Fu et al. · Cancer Science · 2019 · 79 citations · Full text

RON confers lapatinib resistance in HER2-positive breast cancer cells

Quanren Wang, Haitian Quan, Jie Zhao et al. · Cancer Letters · 2013 · 69 citations

, , +5

<scp>STAT</scp>3 activation confers trastuzumab‐emtansine (T‐<scp>DM</scp>1) resistance in <scp>HER</scp>2‐positive breast cancer

Lei Wang, Quanren Wang, Mingzhao Gao et al. · Cancer Science · 2018 · 54 citations · Full text

DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction

Xiangling Chen, Peng Liu, Quanren Wang et al. · Cancer Letters · 2018 · 52 citations

, , +9

YES1 amplification confers trastuzumab–emtansine (T-DM1) resistance in HER2-positive cancer

Lei Wang, Quanren Wang, Piaopiao Xu et al. · British Journal of Cancer · 2020 · 28 citations · Full text

Rows per page

1–5 of 5